Bell JM, Gottlieb T, Daley DA, Coombs GW. Australian group on antimicrobial resistance (AGAR) Australian gram-negative Sepsis outcome Programme (GNSOP) annual report 2017. Commun Dis Intell. 2018;2019:43.
Google Scholar
Kim JM, Park ES, Jeong JS, Kim KM, Kim JM, Oh HS, et al. Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial infection surveillance Committee of the Korean Society for nosocomial infection control. Am J Infect Control. 2000;28(6):454–8. https://doi.org/10.1067/mic.2000.107592.
Article
CAS
PubMed
Google Scholar
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–17. https://doi.org/10.1086/421946.
Article
Google Scholar
Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med. 2000;160(4):501–9. https://doi.org/10.1001/archinte.160.4.501.
Article
CAS
PubMed
Google Scholar
Alikhani MY, Karimi Tabar Z, Mihani F, Kalantar E, Karami P, Sadeghi M, et al. Antimicrobial resistance patterns and prevalence of blaPER-1 and blaVEB-1 genes among ESBL-producing Pseudomonas aeruginosa isolates in west of Iran. Jundishapur J Microbiol. 2014;7(1):e8888. https://doi.org/10.5812/jjm.8888.
Article
PubMed
PubMed Central
Google Scholar
Schimpff SC, Greene WH, Young VM, Wiernik PH. Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma. J Infect Dis. 1974;130 Suppl(0):S24–31.
Article
CAS
Google Scholar
Tapper ML, Armstrong D. Bacteremia due to Pseudomonas aeruginosa complicating neoplastic disease: a progress report. J Infect Dis. 1974;130 Suppl(0):S14–23.
Article
CAS
Google Scholar
Lodise TP Jr, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, et al. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007;51(10):3510–5. https://doi.org/10.1128/AAC.00338-07.
Article
CAS
PubMed
PubMed Central
Google Scholar
Maschmeyer G, Braveny I. Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis. 2000;19(12):915–25. https://doi.org/10.1007/s100960000410.
Article
CAS
PubMed
Google Scholar
Siegman-Igra Y, Ravona R, Primerman H, Giladi M. Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis. 1998;2(4):211–5. https://doi.org/10.1016/S1201-9712(98)90055-8.
Article
CAS
PubMed
Google Scholar
Todeschini G, Franchini M, Tecchio C, Meneghini V, Pizzolo G, Veneri D, et al. Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies. Int J Infect Dis. 1998;3(2):99–104. https://doi.org/10.1016/s1201-9712(99)90017-6.
Article
PubMed
Google Scholar
Vidal F, Mensa J, Almela M, Martinez JA, Marco F, Casals C, et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med. 1996;156(18):2121–6. https://doi.org/10.1001/archinte.1996.00440170139015.
Article
CAS
PubMed
Google Scholar
Bai AD, Showler A, Burry L, Steinberg M, Ricciuto DR, Fernandes T, et al. Impact of infectious disease consultation on quality of care, mortality, and length of stay in Staphylococcus aureus bacteremia: results from a large multicenter cohort study. Clin Infect Dis. 2015;60(10):1451–61. https://doi.org/10.1093/cid/civ120.
Article
PubMed
Google Scholar
Lahey T, Shah R, Gittzus J, Schwartzman J, Kirkland K. Infectious diseases consultation lowers mortality from Staphylococcus aureus bacteremia. Medicine (Baltimore). 2009;88(5):263–7. https://doi.org/10.1097/MD.0b013e3181b8fccb.
Article
Google Scholar
Rieg S, Kupper MF. Impact of an infectious diseases consultation service on the quality of care and the survival of patients with infectious diseases. Z Evid Fortbild Qual Gesundhwes. 2015;109(7):500–10. https://doi.org/10.1016/j.zefq.2015.09.008.
Article
PubMed
Google Scholar
Saunderson RB, Gouliouris T, Nickerson EK, Cartwright EJ, Kidney A, Aliyu SH, et al. Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults. Clin Microbiol Infect. 2015;21(8):779–85. https://doi.org/10.1016/j.cmi.2015.05.026.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vogel M, Schmitz RP, Hagel S, Pletz MW, Gagelmann N, Scherag A, et al. Infectious disease consultation for Staphylococcus aureus bacteremia - a systematic review and meta-analysis. J Inf Secur. 2016;72(1):19–28.
Google Scholar
Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46(7):1000–8. https://doi.org/10.1086/529190.
Article
PubMed
Google Scholar
Burnham JP, Olsen MA, Stwalley D, Kwon JH, Babcock HM, Kollef MH. Infectious diseases consultation reduces 30-day and 1-year all-cause mortality for multidrug-resistant organism infections. Open Forum Infect Dis. 2018;5(3):ofy026.
Article
Google Scholar
Kobayashi T, Marra AR, Schweizer ML, Ten Eyck P, Wu C, Alzunitan M, et al. Impact of infectious disease consultation in patients with candidemia: a retrospective study, systematic literature review, and meta-analysis. Open Forum Infect Dis. 2020;7(9):ofaa270.
Article
Google Scholar
Lagrou K, Van Wijngaerden E. Infectious disease consultation lowers candidaemia mortality. Lancet Infect Dis. 2019;19(12):1270–2. https://doi.org/10.1016/S1473-3099(19)30522-5.
Article
PubMed
Google Scholar
Spec A, Olsen MA, Raval K, Powderly WG. Impact of infectious diseases consultation on mortality of Cryptococcal infection in patients without HIV. Clin Infect Dis. 2017;64(5):558–64. https://doi.org/10.1093/cid/ciw786.
Article
CAS
PubMed
PubMed Central
Google Scholar
Furuichi M, Furuichi M, Horikoshi Y, Miyairi I. Infectious diseases consultation improves treatment and decreases mortality by Enterococcal bacteremia in children. Pediatr Infect Dis J. 2018;37(9):856–60. https://doi.org/10.1097/INF.0000000000001919.
Article
PubMed
Google Scholar
Lee RA, Vo DT, Zurko JC, Griffin RL, Rodriguez JM, Camins BC. Infectious diseases consultation is associated with decreased mortality in enterococcal bloodstream infections. Open Forum Infect Dis. 2020;7(3):ofaa064.
Article
Google Scholar
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. https://doi.org/10.1016/0021-9681(87)90171-8.
Article
CAS
Google Scholar
Kelly H, editor. Therapeutic Guidelines - Antibiotic 16 ed. Melbourne, Australia 2019.
Chesdachai S, Kline S, Helmin D, Rajasingham R. The effect of infectious diseases consultation on mortality in hospitalized patients with methicillin-resistant Staphylococcus aureus, candida, and pseudomonas bloodstream infections. Open Forum Infect Dis. 2020;7(1):ofaa010.
Article
Google Scholar
Tang G, Huang L, Zong Z. Impact of infectious disease consultation on clinical management and outcome of patients with bloodstream infection: a retrospective cohort study. Sci Rep. 2017;7(1):12898. https://doi.org/10.1038/s41598-017-13055-2.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, et al. Comparison of the complexity of patients seen by different medical subspecialists in a universal health care system. JAMA Netw Open. 2018;1(7):e184852. https://doi.org/10.1001/jamanetworkopen.2018.4852.
Article
PubMed
PubMed Central
Google Scholar
McQuillen DP, MacIntyre AT. The value that infectious diseases physicians bring to the healthcare system. J Infect Dis. 2017;216(suppl_5):S588–S93.
Article
Google Scholar
Arancibia F, Bauer TT, Ewig S, Mensa J, Gonzalez J, Niederman MS, et al. Community-acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med. 2002;162(16):1849–58. https://doi.org/10.1001/archinte.162.16.1849.
Article
PubMed
Google Scholar
Charles PG, Whitby M, Fuller AJ, Stirling R, Wright AA, Korman TM, et al. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy. Clin Infect Dis. 2008;46(10):1513–21. https://doi.org/10.1086/586749.
Article
CAS
PubMed
Google Scholar
Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis. 2003;37(6):745–51. https://doi.org/10.1086/377200.
Article
PubMed
Google Scholar
Aliaga L, Mediavilla JD, Cobo F. A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia. J Med Microbiol. 2002;51(7):615–9. https://doi.org/10.1099/0022-1317-51-7-615.
Article
PubMed
Google Scholar
Zhang Q, Smith JC, Zhu Q, Guo Z, MacDonald NE. A five-year review of Pseudomonas aeruginosa bacteremia in children hospitalized at a single center in southern China. Int J Infect Dis. 2012;16(8):e628–32. https://doi.org/10.1016/j.ijid.2012.03.014.
Article
PubMed
Google Scholar
Pasco JA, Nicholson GC, Kotowicz MA. Cohort profile: Geelong osteoporosis study. Int J Epidemiol. 2012;41(6):1565–75. https://doi.org/10.1093/ije/dyr148.
Article
PubMed
Google Scholar
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–10. https://doi.org/10.1001/jama.2016.0287.
Article
CAS
PubMed
PubMed Central
Google Scholar
Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, et al. Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study. Int J Antimicrob Agents. 2020;55(2):105847. https://doi.org/10.1016/j.ijantimicag.2019.11.004.
Article
CAS
PubMed
Google Scholar
Madaline T, Wadskier Montagne F, Eisenberg R, Mowrey W, Kaur J, Malik M, et al. Early infectious disease consultation is associated with lower mortality in patients with severe sepsis or septic shock who complete the 3-hour sepsis treatment bundle. Open Forum Infect Dis. 2019;6(10):ofz408.
Article
Google Scholar